Published February 27, 2020 | Version v1
Journal article Open

Estimating the burden of iron deficiency among African children

  • 1. Centre for Geographic Medicine Research-Coast, KEMRI-Wellcome Trust Research Programme, Kenya Medical Research Institute (KEMRI), Kilifi, Kenya
  • 2. Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
  • 3. MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
  • 4. Department of Clinical Biochemistry, Oxford University Hospitals, Oxford, UK
  • 5. Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • 6. Groupe de Recherche Action en Sante (GRAS), Ouagadougou 06, 06 BP 10248, Burkina Faso
  • 7. Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia
  • 8. Department of Pediatrics, Emory University and Emory Global Health Institute, Atlanta, GA, USA
  • 9. Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda

Description

Background: Iron deficiency (ID) is a major public health burden in African children and accurate prevalence estimates are important for effective nutritional interventions. However, ID may be incorrectly estimated in Africa because most measures of iron status are altered by inflammation and infections such as malaria. Through the current study, we have assessed different approaches to the prediction of iron status and estimated the burden of ID in African children.

Methods: We assayed iron and inflammatory biomarkers in 4853 children aged 0–8 years from Kenya, Uganda, Burkina Faso, South Africa, and The Gambia. We described iron status and its relationship with age, sex, inflammation, and malaria parasitemia. We defined ID using the WHO guideline (ferritin < 12 μg/L or < 30 μg/L in the presence of inflammation in children < 5 years old or < 15 μg/L in children ≥ 5 years old). We compared this with a recently proposed gold standard, which uses regression-correction for ferritin levels based on the relationship between ferritin levels, inflammatory markers, and malaria. We further investigated the utility of other iron biomarkers in predicting ID using the inflammation and malaria regression-corrected estimate as a gold standard.

Results: The prevalence of ID was highest at 1 year of age and in male infants. Inflammation and malaria parasitemia were associated with all iron biomarkers, although transferrin saturation was least affected. Overall prevalence of WHO-defined ID was 34% compared to 52% using the inflammation and malaria regression-corrected estimate. This unidentified burden of ID increased with age and was highest in countries with high prevalence of inflammation and malaria, where up to a quarter of iron-deficient children were misclassified as iron replete. Transferrin saturation < 11% most closely predicted the prevalence of ID according to the regression-correction gold standard.

Conclusions: The prevalence of ID is underestimated in African children when defined using the WHO guidelines, especially in malaria-endemic populations, and the use of transferrin saturation may provide a more accurate approach. Further research is needed to identify the most accurate measures for determining the prevalence of ID in sub-Saharan Africa.

Files

12916_2020_1502_MOESM4_ESM.png

Files (3.5 MB)

Name Size Download all
md5:ae2ce7ebb6cc06c7c676f8834e11d23e
18.0 kB Download
md5:7369a9643ec947e93d24efa5de4f3606
17.6 kB Download
md5:208f8007ec721baaed6229cf4d050cc3
24.8 kB Download
md5:15d00beafebf2a72b5e5d255e2ff2443
405.9 kB Preview Download
md5:3623b04c52ff9ce4aa1b97b9189ef245
78.7 kB Preview Download
md5:ff4f3e99924ff697d931488e0c2695cb
165.4 kB Preview Download
md5:0b7ddc25d043f8e2410a79b1865d4219
68.7 kB Preview Download
md5:ac609d6864cdd1ab781cee5d01065c37
2.7 MB Preview Download
md5:8bab780f180e94c2ab2f4ce00d0c5b0b
23.9 kB Download

Additional details

Funding

IMMUNOGENE – Immunogenetics of Severe Bacterial Disease Susceptibility and Vaccine Responses in Humans 294557
European Commission